Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Anthera Pharmaceuticals (ANTH)’

BRIDGER MANAGEMENT

Roberto Mignone’s New Stock Picks

When Roberto Mignone graduated from Harvard Business School, he joined John Griffin at Blue Ridge Capital. Right before his 29th birthday in July 2000......(read more)

Samuel Isaly and OrbiMed Advisors Reduced Anthera Pharmaceuticals $ANTH

Samuel Isaly’s OrbiMed Advisors manages around $5 Billion in healthcare related equities and venture capital. Eaton Vance Worldwide Health Sciences......(read more)